Identification and characterization of vaccinia virus genes encoding proteins that are highly antigenic in animals and are immunodominant in vaccinated humans
- PMID: 1727494
- PMCID: PMC238298
- DOI: 10.1128/JVI.66.1.386-398.1992
Identification and characterization of vaccinia virus genes encoding proteins that are highly antigenic in animals and are immunodominant in vaccinated humans
Abstract
Vaccinia virus (VV) is a potent immunogen, but the nature of VV proteins involved in the activation of the immune response of the host is not yet known. By screening a lambda gt11 expression library of rabbitpox virus DNA with serum from humans vaccinated against smallpox or with serum from VV-immunized animals, we identified several VV genes that encode highly antigenic viral proteins with molecular masses of 62, 39, 32, 25, 21, and 14 kDa. It was found that VV proteins of 62, 39, 25, and 21 kDa are part of the virus core, while proteins of 32 and 14 kDa are part of the virus envelope. All of these proteins were synthesized at late times postinfection. Proteins of 62 and 25 kDa were produced by cleavage of larger precursors of 95 kDa (p4a) and 28 kDa, respectively. The 21-kDa protein was the result of a cleavage of p4a, presumably at amino acid Gly-697. DNA sequence analysis, in comparison with the known nucleotide sequence of VV, provided identification of the corresponding open reading frames. Expression of the viral genes in Escherichia coli was used to monitor which of the viral antigens elicit immunodominant responses and the location of antigenic domains. Three viral antigens of 62, 39, and 32 kDa exhibited immunodominant characteristics. The most antigenic sites of 62 and 39 kDa were identified at the N terminus (amino acids 132 to 295) and C terminus (last 103 amino acids), respectively. Immunization of mice with the 62-, 39-, or 14-kDa antigenic proteins conferred different degrees of protection from VV challenge. Proteins of 32 and 14 kDa induced cellular proliferative responses in VV-infected mice. Our findings demonstrate the nature of VV proteins involved in the activation of host immune responses after vaccination, provide identification of the viral gene locus, and define structural and immunological properties of these antigenic VV proteins.
Similar articles
-
The purified 14-kilodalton envelope protein of vaccinia virus produced in Escherichia coli induces virus immunity in animals.J Virol. 1991 Oct;65(10):5631-5. doi: 10.1128/JVI.65.10.5631-5635.1991. J Virol. 1991. PMID: 1654459 Free PMC article.
-
Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus.J Virol. 1987 Dec;61(12):3855-61. doi: 10.1128/JVI.61.12.3855-3861.1987. J Virol. 1987. PMID: 3316707 Free PMC article.
-
Characterization of the immune response elicited by the vaccinia virus L3 protein delivered as naked DNA.Vaccine. 2018 Apr 5;36(15):2049-2055. doi: 10.1016/j.vaccine.2018.02.033. Epub 2018 Mar 7. Vaccine. 2018. PMID: 29525282 Free PMC article.
-
Vaccinia virus pathogenicity in atopic dermatitis is caused by allergen-induced immune response that prevents the antiviral cellular and humoral immunity.Virus Genes. 2003 Dec;27(3):269-82. doi: 10.1023/a:1026399916888. Virus Genes. 2003. PMID: 14618088 Review.
-
An overview of the vaccinia virus infectome: a survey of the proteins of the poxvirus-infected cell.J Virol. 2012 Feb;86(3):1487-99. doi: 10.1128/JVI.06084-11. Epub 2011 Nov 16. J Virol. 2012. PMID: 22090131 Free PMC article. Review.
Cited by
-
The pox in the North American backyard: Volepox virus pathogenesis in California mice (Peromyscus californicus).PLoS One. 2012;7(8):e43881. doi: 10.1371/journal.pone.0043881. Epub 2012 Aug 28. PLoS One. 2012. PMID: 22952799 Free PMC article.
-
PREVALENCE OF ANTIBODIES TO ORTHOPOXVIRUS IN WILD CARNIVORES OF NORTHWESTERN CHIHUAHUA, MEXICO.J Wildl Dis. 2019 Jul;55(3):637-644. Epub 2019 Mar 1. J Wildl Dis. 2019. PMID: 30822210 Free PMC article.
-
Multivalent smallpox DNA vaccine delivered by intradermal electroporation drives protective immunity in nonhuman primates against lethal monkeypox challenge.J Infect Dis. 2011 Jan 1;203(1):95-102. doi: 10.1093/infdis/jiq017. J Infect Dis. 2011. PMID: 21148501 Free PMC article.
-
Identification of Poxvirus Genome Uncoating and DNA Replication Factors with Mutually Redundant Roles.J Virol. 2018 Mar 14;92(7):e02152-17. doi: 10.1128/JVI.02152-17. Print 2018 Apr 1. J Virol. 2018. PMID: 29343579 Free PMC article.
-
Single-shot immunization with recombinant adenovirus encoding vaccinia virus glycoprotein A27L is protective against a virulent respiratory poxvirus infection.Vaccine. 2010 Jul 12;28(31):4997-5004. doi: 10.1016/j.vaccine.2010.05.023. Vaccine. 2010. PMID: 20653083 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials